Evolus, Inc. Common Stock

13.31 USD
+0.15 (+1.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Evolus, Inc. Common Stock stock is up 14.45% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 6 February’s closed higher than January. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jan 17:43 19 Jan, 2024 10.00 CALL 1472 8701

About Evolus, Inc. Common Stock

Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. Jeuveau is a proprietary 900 kilodalton purified botulinum toxin type A formulation for the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.